Literature DB >> 6704284

Comparison of methods for estimating gentamicin clearance and retrospective analysis of changes in clearance with emphasis on patients with normal renal function.

P G Davey, A M Geddes, I Gonda, E S Harpur, D K Scott.   

Abstract

The subjects were 29 general medical and surgical patients with apparently normal renal function at the start of treatment with gentamicin. Nine methods of estimating gentamicin clearance (CL) were compared as means of calculating gentamicin dosage. In 23 of the 29 patients CL was measured twice during treatment. The first measurement was based on 10 blood samples taken around a dose early in treatment. CL calculated from the area under the serum concentration-time curve using all 10 samples was designated a reference method for comparison with other methods. There was considerable inter-individual variation in CL. Serum creatinine and body weight gave poor estimates of an individual's CL. A good estimate of CL was obtained from four blood samples taken immediately before and 2, 3 and 4 h after dosing. Prediction of serum levels is not a good method for checking CL estimations. A significant decrease in CL was found during treatment. This was probably due to a reduction in glomerular filtration rate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704284      PMCID: PMC1463321          DOI: 10.1111/j.1365-2125.1984.tb02329.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Calculating gentamicin doses.

Authors:  J S Raichlen
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

3.  Gentamicin serum concentrations: pharmacokinetic predictions.

Authors:  J H Hull; F A Sarubbi
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

4.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

5.  The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.

Authors:  D Kaye; M E Levison; E D Labovitz
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

6.  [Estimation of glomerular filtration from creatininemia].

Authors:  L Jadrný
Journal:  Cas Lek Cesk       Date:  1965-09-03

7.  Prediction of gentamicin serum levels using a one-compartment open linear pharmacokinetic model.

Authors:  M Chow; J Deglin; A Harralson; R Bartlett; R Quintiliani
Journal:  Am J Hosp Pharm       Date:  1978-09

8.  Gentamicin therapy in renal failure: a nomogram for dosage.

Authors:  R A Chan; E J Benner; P D Hoeprich
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

9.  Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration.

Authors:  M C McHenry; T L Gavan; R W Gifford; N A Geurkink; R A Van Ommen; M A Town; J G Wagner
Journal:  Ann Intern Med       Date:  1971-02       Impact factor: 25.391

10.  Predictability of peak serum gentamicin concentration with dosage based on body surface area.

Authors:  G R Siber; A L Smith; M J Levin
Journal:  J Pediatr       Date:  1979-01       Impact factor: 4.406

View more
  3 in total

1.  Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.

Authors:  F A Zantvoort; J H Wagenvoort; F H Derkx; M F Michel
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

2.  Population pharmacokinetics of amikacin in critically ill patients.

Authors:  F Bressolle; A Gouby; J M Martinez; P Joubert; G Saissi; R Guillaud; R Gomeni
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

3.  A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients.

Authors:  K Hickling; E Begg; M L Moore
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.